Skip Navigation


JAC Advance Access originally published online on July 25, 2008
Journal of Antimicrobial Chemotherapy 2008 62(5):1057-1060; doi:10.1093/jac/dkn312
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
62/5/1057    most recent
dkn312v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sauermann, R.
Right arrow Articles by Zeitlinger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sauermann, R.
Right arrow Articles by Zeitlinger, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Antimicrobial activity of cefepime and rifampicin in cerebrospinal fluid in vitro

Robert Sauermann1,*, Richard Schwameis1, Manfred Fille2, Maria Luciana Camuz Ligios1 and Markus Zeitlinger1

1 Division of Molecular Pharmacokinetics and Imaging, Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria 2 Department of Hygiene, Microbiology and Social Medicine, Innsbruck Medical University, Fritz-Pregl-Straße 3, 6020 Innsbruck, Austria

Received 30 April 2008; returned 21 May 2008; revised 2 July 2008; accepted 8 July 2008


* Corresponding author. Tel: +43-1-40400-2981; Fax: +43-1-40400-2998; E-mail: robert.sauermann{at}meduniwien.ac.at

Objectives: Though used for infections of the central nervous system, the pharmacodynamics of antimicrobial agents is commonly evaluated only in commercially available bacterial growth media. In the present study, the effects of cerebrospinal fluid (CSF) on bacterial killing by cefepime and rifampicin were investigated.

Methods: CSF was collected from patients who did not receive antibiotics. Time–kill curves were performed over 24 h using drug concentrations of 0.25-, 0.5-, 1-, 2-, 4- and 8-fold the respective MIC for the Staphylococcus aureus test strain. Killing curves were performed in Mueller–Hinton broth (MHB), in CSF incubated in ambient air (CSFAIR) and in CSF in air with 5% CO2 (CSFCO2). CO2 served to adjust the pH of CSF to physiological values.

Results: Sustained bacterial killing was achieved by cefepime at lower drug concentrations in CSFCO2 than in MHB. In contrast, rifampicin concentrations above the MIC were required to exert sustained killing in CSFCO2. Both drugs were least effective in CSFAIR.

Conclusions: Standard susceptibility tests may lead to over- or underestimation of the activity of distinct antibiotics in CSF. Evaluation of the antimicrobial activity in pH-adjusted CSF can provide useful information on drugs considered for the treatment of bacterial infections residing in CSF.

Keywords: bacterial killing , CSF , pH , CO2


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
R. Sauermann, R. Schwameis, M. Fille, M. L. Camuz Ligios, and M. Zeitlinger
Cerebrospinal fluid impairs antimicrobial activity of fosfomycin in vitro
J. Antimicrob. Chemother., October 1, 2009; 64(4): 821 - 823.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.